MARKET

TBPH

TBPH

Theravance Bioph
NASDAQ
9.17
-0.05
-0.54%
After Hours: 9.17 0 0.00% 16:02 04/24 EDT
OPEN
9.14
PREV CLOSE
9.22
HIGH
9.26
LOW
9.05
VOLUME
297.15K
TURNOVER
0
52 WEEK HIGH
11.98
52 WEEK LOW
8.21
MARKET CAP
445.29M
P/E (TTM)
-9.1884
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at TBPH last week (0415-0419)?
Weekly Report · 2d ago
Surprising Analyst 12-Month Target For VB
NASDAQ · 5d ago
Weekly Report: what happened at TBPH last week (0408-0412)?
Weekly Report · 04/15 11:56
Strength Seen in Theravance Bio (TBPH): Can Its 7.6% Jump Turn into More Strength?
NASDAQ · 04/15 11:47
Health Care Sector Update for 04/12/2024: ZTS, NUTX, TBPH
NASDAQ · 04/12 17:48
Veru, Theravance Biopharma, Adial Pharmaceuticals among healthcare movers
Seeking Alpha · 04/12 14:00
Theravance Biopharma Initiated at Buy by BTIG
Dow Jones · 04/12 11:51
BTIG Initiates Coverage On Theravance Biopharma with Buy Rating, Announces Price Target of $21
Benzinga · 04/12 11:42
More
About TBPH
Theravance Biopharma, Inc. is a biopharmaceutical company primarily focused on the development, and commercialization of medicines. Its product, YUPELRI (revefenacin) inhalation solution is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). YUPELRI is a prescription medicine used to treat COPD, a long-term lung disease that includes chronic bronchitis, emphysema, or both. YUPELRI is an anticholinergic medicine, which helps the muscles around the airway in lungs stay relaxed to prevent symptoms, such as wheezing, shortness of breath and others. Its pipeline of internally discovered programs is targeted to address unmet patient needs. Ampreloxetine, its late-stage investigational norepinephrine reuptake inhibitor in development for symptomatic neurogenic orthostatic hypotension. Its Selective 5-HT4 Agonist (TD-8954) is a selective 5-HT4 receptor agonist, which is developed for the treatment of gastrointestinal motility disorders.

Webull offers Theravance Biopharma Inc stock information, including NASDAQ: TBPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TBPH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TBPH stock methods without spending real money on the virtual paper trading platform.